Breast cancer susceptibility genes. BRCA1 and BRCA2.
暂无分享,去创建一个
[1] B. Trask,et al. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. , 1998, Human molecular genetics.
[2] J. Parvin,et al. Factors associated with the mammalian RNA polymerase II holoenzyme. , 1998, Nucleic acids research.
[3] S. Miesfeldt,et al. A novel BRCA1 mutation in an identical twin pair with similar clinical histories. , 1998, Cancer genetics and cytogenetics.
[4] P. Bartel,et al. RAD51 Interacts with the Evolutionarily Conserved BRC Motifs in the Human Breast Cancer Susceptibility Gene brca2 * , 1997, The Journal of Biological Chemistry.
[5] A. Ashworth,et al. Nuclear location and cell cycle regulation of the BRCA2 protein. , 1997, Cancer research.
[6] E. Marshall. The Battle Over BRCA1 Goes to Court; BRCA2 May Be Next , 1997, Science.
[7] A. Ashworth,et al. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation , 1997, Nature Genetics.
[8] Benjamin S. Wilfond,et al. Cancer Genetic Susceptibility Testing: Ethical and Policy Implications for Future Research and Clinical Practice , 1997, Journal of Law, Medicine & Ethics.
[9] Peter Devilee,et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients , 1997, Nature Genetics.
[10] V. Grann. Risk of breast cancer in carriers of BRCA gene mutations. , 1997, The New England journal of medicine.
[11] O. Díez,et al. Differences in phenotypic expression of a new BRCA1 mutation in identical twins , 1997, The Lancet.
[12] G. Lozano,et al. The Li-Fraumeni syndrome: an inherited susceptibility to cancer. , 1997, Molecular medicine today.
[13] M N Pollak,et al. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women , 1997, Cancer.
[14] D. Easton. Breast cancer genes—what are the real risks? , 1997, Nature Genetics.
[15] F. Alt,et al. RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[16] F. Collins,et al. Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Young,et al. BRCA1 is a component of the RNA polymerase II holoenzyme. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Stratton. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.
[19] T. Ludwig,et al. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. , 1997, Genes & development.
[20] T. Mak,et al. Brca2 is required for embryonic cellular proliferation in the mouse. , 1997, Genes & development.
[21] F. Couch,et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. , 1997, The New England journal of medicine.
[22] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[23] B. Wilfond,et al. Genetic Testing for Susceptibility to Adult-Onset Cancer: The Process and Content of Informed Consent , 1997 .
[24] B. Biesecker,et al. Psychological issues in cancer genetics. , 1997, Seminars in oncology nursing.
[25] J. Eyfjörd,et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. , 1997, American journal of human genetics.
[26] Charis Eng,et al. Genetic testing: The problems and the promise , 1997, Nature Biotechnology.
[27] G. Pals,et al. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. , 1997, American journal of human genetics.
[28] Luke Hughes-Davies,et al. Transcriptional activation functions in BRCA2 , 1997, Nature.
[29] Bert Vogelstein,et al. Gatekeepers and caretakers , 1997, Nature.
[30] G. Eichele,et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.
[31] H. Gardner,et al. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. , 1997, Developmental biology.
[32] J Isola,et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. , 1997, Cancer research.
[33] E. Thomson,et al. Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .
[34] K Offit,et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. , 1997, JAMA.
[35] A S Whittemore,et al. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. , 1997, American journal of human genetics.
[36] I. Lerer,et al. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. , 1997, American journal of human genetics.
[37] A. Bradley,et al. Murine Brca2: sequence, map position, and expression pattern. , 1997, Genomics.
[38] P. Tonin,et al. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? , 1997, American journal of human genetics.
[39] P. Schlag,et al. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families , 1997, Oncogene.
[40] E. Marshall. Federal Regulation: Gene Tests Get Tested , 1997, Science.
[41] A. Ashworth,et al. Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. , 1997, Human molecular genetics.
[42] Yonghong Xiao,et al. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.
[43] J. Benkendorf,et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. , 1997, Journal of the National Cancer Institute.
[44] R. Gatti,et al. Diversity of ATM gene mutations detected in patients with ataxia‐telangiectasia , 1997, Human mutation.
[45] Y. Shiloh,et al. The genetic defect in ataxia-telangiectasia. , 1997, Annual review of immunology.
[46] J. E. Nash,et al. Psychological responses to BRCA1 mutation testing: preliminary findings. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[47] D. Evans,et al. Li-Fraumeni syndrome--a molecular and clinical review. , 1997, British Journal of Cancer.
[48] Yumay Chen,et al. The Nuclear Localization Sequences of the BRCA1 Protein Interact with the Importin-α Subunit of the Nuclear Transport Signal Receptor* , 1996, The Journal of Biological Chemistry.
[49] Anne M. Bowcock,et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product , 1996, Nature Genetics.
[50] L. Chodosh,et al. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[51] M. Morgan,et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. , 1996, The New England journal of medicine.
[52] O. Olopade. Genetics in clinical cancer care--the future is now. , 1996, The New England journal of medicine.
[53] L. Hood,et al. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. , 1996, Genome research.
[54] M. Stratton,et al. A polymorphic stop codon in BRCA2 , 1996, Nature Genetics.
[55] Alfred A. Boyd,et al. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 , 1996, Nature Genetics.
[56] Kenneth Offit,et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% , 1996, Nature Genetics.
[57] N Risch,et al. The Future of Genetic Studies of Complex Human Diseases , 1996, Science.
[58] M. King,et al. Human, canine and murine BRCA1 genes: sequence comparison among species. , 1996, Human molecular genetics.
[59] I. Verma,et al. Transcriptional activation by BRCA1 , 1996, Nature.
[60] B. Ponder,et al. Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. , 1996, Cancer research.
[61] D. Easton,et al. High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. , 1996, Cancer research.
[62] C. Liu,et al. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. , 1996, Genes & development.
[63] Y. Chen,et al. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. , 1996, Cancer research.
[64] N. Shao,et al. Induction of apoptosis by the tumor suppressor protein BRCA1. , 1996, Oncogene.
[65] K. Kerlikowske,et al. Effect of age, breast density, and family history on the sensitivity of first screening mammography. , 1996, JAMA.
[66] J. E. Nash,et al. A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. , 1996, Journal of the National Cancer Institute.
[67] Eugene V. Koonin,et al. …Functional motifs… , 1996, Nature Genetics.
[68] Borg A,et al. Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization. , 1996, Cancer research.
[69] J. Rossant,et al. The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse , 1996, Cell.
[70] B. Trock,et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.
[71] K Offit,et al. Germline BRCA1 185delAG mutations in Jewish women with breast cancer , 1996, The Lancet.
[72] M. Skolnick,et al. Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. , 1996, Human molecular genetics.
[73] J. Sklar,et al. Practical methods of mutation detection. , 1996, Current opinion in genetics & development.
[74] H. Nguyen,et al. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[75] W. Thompson,et al. The genetic attributable risk of breast and ovarian cancer , 1996, Cancer.
[76] D. B. Berman,et al. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. , 1996, American journal of human genetics.
[77] Sheila Seal,et al. BRCA2 mutations in primary breast and ovarian cancers , 1996, Nature Genetics.
[78] M. Skolnick,et al. Low incidence of BRCA2 mutations in breast carcinoma and other cancers , 1996, Nature Genetics.
[79] Yusuke Nakamura,et al. Mutation analysis in the BRCA2 gene in primary breast cancers , 1996, Nature Genetics.
[80] T. Darden,et al. Molecular modeling of the amino-terminal zinc ring domain of BRCA1. , 1996, Cancer research.
[81] H. Breiteneder,et al. New Austrian mutation in BRCA1 gene detected in three unrelated HBOC families , 1996, The Lancet.
[82] J. Eyfjörd,et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes , 1996, Nature Genetics.
[83] Kenneth Offit,et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer , 1996, Nature Genetics.
[84] J. Rommens,et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families , 1996, Nature Genetics.
[85] C. Osborne,et al. Location of BRCA1 in Human Breast and Ovarian Cancer Cells , 1996, Science.
[86] R. Berkowitz,et al. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls. , 1996, Cancer research.
[87] Cécile Fizames,et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites , 1996, Nature.
[88] Suzanne M. Miller,et al. A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. , 1996, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[89] M. King,et al. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. , 1996, American journal of human genetics.
[90] J. Rommens,et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.
[91] M. King,et al. Growth retardation and tumour inhibition by BRCA1 , 1996, Nature Genetics.
[92] M. King,et al. BRCA1 is secreted and exhibits properties of a granin , 1996, Nature Genetics.
[93] G. Gyapay,et al. A radiation hybrid map of the human genome. , 1996, Human molecular genetics.
[94] R. Berkowitz,et al. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. , 1996, Oncogene.
[95] Peters Ja,et al. ROLE OF THE GENETIC COUNSELOR IN FAMILIAL CANCER , 1996 .
[96] B. Koller,et al. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities , 1996, Nature Genetics.
[97] Barbara L. Smith,et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. , 1996, The New England journal of medicine.
[98] F. Collins. BRCA1--lots of mutations, lots of dilemmas. , 1996, The New England journal of medicine.
[99] M. Skolnick,et al. Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries , 1996 .
[100] C. Harris,et al. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy. , 1996, Cancer surveys.
[101] F. Collins,et al. The geneticist's approach to complex disease. , 1996, Annual review of medicine.
[102] D. Bentley,et al. Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.
[103] M. King,et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. , 1995, American journal of human genetics.
[104] B. Weber,et al. Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains. , 1995, Human molecular genetics.
[105] D. Easton,et al. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. , 1995, American journal of human genetics.
[106] Gail Geller,et al. Informed consent and BRCA1 testing , 1995, Nature Genetics.
[107] D. Dickson. UK court rejects appeal over hepatitis C kits , 1995, Nature.
[108] C. Osborne,et al. Aberrant Subcellular Localization of BRCA1 in Breast Cancer , 1995, Science.
[109] Mckusick Va. Reviews in molecular medicine. , 1995 .
[110] M. Ergazaki,et al. Loss of heterozygosity at 9p and 17q in human laryngeal tumors. , 1995, Cancer letters.
[111] K H Rothenberg,et al. Genetic Discrimination and Health Insurance: An Urgent Need for Reform , 1995, Science.
[112] H. Nguyen,et al. Hormone-dependent regulation of BRCA1 in human breast cancer cells. , 1995, Cancer research.
[113] L. Bennett,et al. Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11. , 1995, Genomics.
[114] F. Collins,et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals , 1995, Nature Genetics.
[115] R. Kandpal,et al. Molecular cloning and expression pattern of genes from a 470 Kb region near BRCA1 locus on chromosome 17q21. , 1995, Oncogene.
[116] Junzhe Xu,et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues , 1995, Nature Genetics.
[117] J. Rommens,et al. Generation of a transcription map at the HSD17B locus centromeric to BRCA1 at 17q21. , 1995, Genomics.
[118] Y. Miki,et al. Comparison of the positional cloning methods used to isolate the BRCA1 gene. , 1995, Human molecular genetics.
[119] P. Tonin,et al. BRCA1 mutations in Ashkenazi Jewish women. , 1995, American journal of human genetics.
[120] R. McFarlane,et al. A human BRCA1 gene knockout , 1995, Nature.
[121] R. Glass,et al. Frontometaphyseal dysplasia: neonatal radiographic diagnosis. , 1995, American journal of medical genetics.
[122] H. Lehrach,et al. Physical mapping, cloning, and identification of genes within a 500-kb region containing BRCA1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[123] M. Seller,et al. Unusual case of Smith-Lemli-Opitz syndrome "type II". , 1995, American journal of medical genetics.
[124] David L. Page,et al. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression , 1995, Nature Genetics.
[125] A. Berchuck,et al. Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer. , 1995, American journal of obstetrics and gynecology.
[126] T. Rebbeck,et al. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. , 1995, JAMA.
[127] M. Skolnick,et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. , 1995, JAMA.
[128] B. Rimer,et al. Effects of individualized breast cancer risk counseling: a randomized trial. , 1995, Journal of the National Cancer Institute.
[129] A. Motulsky. Jewish diseases and origins , 1995, Nature Genetics.
[130] N. Risch,et al. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population , 1995, Nature Genetics.
[131] M. Skolnick,et al. A physical map encompassing GP2B, EPB3, D17S183, D17S78, D17S1183, and D17S1184. , 1995, Genomics.
[132] Ming K. Lee,et al. 22 genes from chromosome 17q21: cloning, sequencing, and characterization of mutations in breast cancer families and tumors. , 1995, Genomics.
[133] F. Couch,et al. Construction of a transcription map surrounding the BRCA1 locus of human chromosome 17. , 1995, Genomics.
[134] R. Eeles. Germline mutations in the TP53 gene. , 1995, Cancer surveys.
[135] M. Stratton,et al. Breast cancer susceptibility: a complex disease unravels. , 1995, Trends in genetics : TIG.
[136] D. Glavač,et al. Applications of heteroduplex analysis for mutation detection in disease genes , 1995, Human mutation.
[137] D. Easton,et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.
[138] A. Whittemore,et al. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.
[139] M. Lovett,et al. Direct selection of expressed sequences within a 1-Mb region flanking BRCA1 on human chromosome 17q21. , 1995, Genomics.
[140] F. Couch,et al. A YAC-, P1-, and cosmid-based physical map of the BRCA1 region on chromosome 17q21. , 1995, Genomics.
[141] S. Mallory. Cowden syndrome (multiple hamartoma syndrome). , 1995, Dermatologic clinics.
[142] F. Collins,et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours , 1995, Nature Genetics.
[143] M. King,et al. The search for BRCA1. , 1994, Cancer research.
[144] F. Collins,et al. Characterization of 10 new polymorphic dinucleotide repeats and generation of a high-density microsatellite-based physical map of the BRCA1 region of chromosome 17q21. , 1994, Genomics.
[145] Francis S. Collins,et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer , 1994, Nature Genetics.
[146] J. Rommens,et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families , 1994, Nature Genetics.
[147] Patrick Dowd,et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families , 1994, Nature Genetics.
[148] S. Neuhausen,et al. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. , 1994, Cancer Research.
[149] L. Cannon-Albright,et al. A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1. , 1994, Human molecular genetics.
[150] K. Jones,et al. The detailed characterisation of a 400 kb cosmid walk in the BRCA1 region: identification and localisation of 10 genes including a dual-specificity phosphatase. , 1994, Human molecular genetics.
[151] M. Skolnick,et al. BRCA1 mutations in primary breast and ovarian carcinomas. , 1994, Science.
[152] K. Kinzler,et al. Has the breast cancer gene been found? , 1994, Cell.
[153] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[154] S. Seal,et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.
[155] B. Henderson,et al. Physical exercise and reduced risk of breast cancer in young women. , 1994, Journal of the National Cancer Institute.
[156] S. Tavtigian,et al. Localization of the VHR phosphatase gene and its analysis as a candidate for BRCA1. , 1994, Genomics.
[157] Y. Miki,et al. Isolation of a diverged homeobox gene, MOX1, from the BRCA1 region on 17q21 by solution hybrid capture. , 1994, Human molecular genetics.
[158] E. Fujimoto,et al. A physical map and candidate genes in the BRCA1 region on chromosome 17q12–21 , 1994, Nature Genetics.
[159] Melissa A. Brown,et al. Towards cloning the familial breast-ovarian cancer gene on chromosome 17. , 1994, Current opinion in genetics & development.
[160] Raymond L. White,et al. Localisation of the breast‐ovarian cancer susceptibility gene (BRCAI) on 17q12–21 to an interval of ⩽IcM , 1994, Genes, chromosomes & cancer.
[161] M. King,et al. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q , 1994, Nature Genetics.
[162] M. Daly,et al. Attitudes about genetic testing for breast-ovarian cancer susceptibility. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[163] R. Bast,et al. A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1. , 1994, Human molecular genetics.
[164] S. Mori,et al. Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus. , 1994, Cancer research.
[165] J. Marks,et al. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line. , 1994, Cancer research.
[166] R. Croyle,et al. Psychological issues in genetic testing for breast cancer susceptibility. , 1994, Archives of internal medicine.
[167] Lloyd M. Smith,et al. Statement on use of DNA testing for presymptomatic identification of cancer risk. National Advisory Council for Human Genome Research. , 1994, JAMA.
[168] N. Risch,et al. Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994 .
[169] P. Tonin,et al. Histology of BRCA1-associated ovarian tumours , 1994, The Lancet.
[170] L. Garfinkel,et al. Changing trends: An overview of breast cancer incidence and mortality , 1994, Cancer.
[171] F. Couch,et al. Progress toward isolation of a breast cancer susceptibility gene, BRCA1. , 1994, Cold Spring Harbor Symposia on Quantitative Biology.
[172] D. Easton. The inherited component of cancer. , 1994, British medical bulletin.
[173] M. King,et al. Green pigs, red herrings, and a golden hoe: a retrospective on the identification of BRCA1 and the beginning of its characterization. , 1994, Cold Spring Harbor symposia on quantitative biology.
[174] M. Stratton,et al. The genetics of familial breast cancer and their practical implications. , 1994, European journal of cancer.
[175] J. Weissenbach,et al. A second generation linkage map of the human genome based on highly informative microsatellite loci. , 1993, Gene.
[176] M. Daly,et al. Ovarian cancer risk counseling: a guide for the practitioner. , 1993, Oncology.
[177] D. Galas,et al. A new five-year plan for the U.S. Human Genome Project. , 1993, Science.
[178] C. Larsson,et al. Loss of heterozygosity in familial breast carcinomas. , 1993, Cancer research.
[179] G. Lenoir,et al. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. , 1993, Archives of internal medicine.
[180] F. Collins,et al. A radiation hybrid map of the BRCA1 region of chromosome 17q12-q21. , 1993, Genomics.
[181] P. Engstrom,et al. Mammography adherence and psychological distress among women at risk for breast cancer. , 1993, Journal of the National Cancer Institute.
[182] M. King,et al. Inherited breast and ovarian cancer. What are the risks? What are the choices? , 1993, JAMA.
[183] F. Collins,et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. , 1993, JAMA.
[184] M. King,et al. THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. , 1993, American journal of human genetics.
[185] J. Simard,et al. Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid dehydrogenase II gene at the EDH17B2 locus on 17q11-q21. , 1993, Human molecular genetics.
[186] D. Kelsell,et al. Linkage analysis of early-onset breast and ovarian cancer families, with markers on the long arm of chromosome 17. , 1993, American journal of human genetics.
[187] R. Norum,et al. BRCA1 maps proximal to D17S579 on chromosome 17q21 by genetic analysis. , 1993, American Journal of Human Genetics.
[188] M. Stratton,et al. Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21. , 1993, American journal of human genetics.
[189] D. Easton,et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.
[190] M H Skolnick,et al. Chromosome 17q linkage studies of 18 Utah breast cancer kindreds. , 1993, American journal of human genetics.
[191] J. Weber,et al. Closing in on a breast cancer gene on chromosome 17q. , 1992, American journal of human genetics.
[192] F. Collins,et al. Positional cloning: Let's not call it reverse anymore , 1992, Nature Genetics.
[193] J. Holland,et al. Psychological distress and surveillance behaviors of women with a family history of breast cancer. , 1992, Journal of the National Cancer Institute.
[194] M R Natowicz,et al. Discrimination as a consequence of genetic testing. , 1992, American journal of human genetics.
[195] B. Hailey. Family history of breast cancer and screening behavior: an inverted U-shaped curve? , 1991, Medical hypotheses.
[196] G. Lenoir,et al. Familial breast-ovarian cancer locus on chromosome 17q12-q23 , 1991, The Lancet.
[197] M. King,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.
[198] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[199] M. King,et al. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. , 1988, Proceedings of the National Academy of Sciences of the United States of America.